1
The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma
Condition(s):Resectable Pancreatic Ductal AdenocarcinomaLast Updated:January 18, 2018Unknown status
Metformin Hydrochloride: 2580 Clinical Trials, Page 1 of 258
Hide Studies Not Open or Pending
2
Glucophage® Extended Release (XR) 750 Milligram (mg) Indonesia Bioequivalence (BE) Study
Condition(s):HealthyLast Updated:November 25, 2019Completed
3
Pharmacokinetics of Metformin Intolerance
Condition(s):Diabetes Mellitus, Type 2; Metformin Adverse ReactionLast Updated:December 5, 2017Completed
4
Metformin in Children and Adults With Fragile X Syndrome
Condition(s):Fragile X SyndromeLast Updated:February 4, 2021Completed
5
A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM
Condition(s):Type 2 Diabetes MellitusLast Updated:June 28, 2021Completed
6
Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions
Condition(s):Oral CancerLast Updated:September 26, 2018Unknown status
7
Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
Condition(s):Osteosarcoma; Ewing SarcomaLast Updated:March 30, 2021Recruiting
8
Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes
Condition(s):Type 1 Diabetes Mellitus; MetforminLast Updated:July 20, 2018Unknown status
9
Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial
Condition(s):Preeclampsia; Preeclampsia Severe; High Risk Pregnancy; EclampsiaLast Updated:May 26, 2021Not yet recruiting
10
Effects of Metformin on Airway Ion Channel Dysfunction in Cystic Fibrosis-related Diabetes
Condition(s):Cystic Fibrosis-related Diabetes; Cystic FibrosisLast Updated:February 15, 2021Not yet recruiting